Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Eating Disorders

 

Group Leader
Dr Amanda Sainsbury-Salis

 
Group Leader
Professor Herbert Herzog

 

One of our laboratory's major goals is to understand how the brain, notably the hypothalamus, regulates appetite and body weight. Defects in the brain pathways that regulate these processes may be responsible for wasting conditions such as anorexia nervosa and cancer cachexia as well as the metabolic resistance to weight loss that often occurs when people try to shed excess weight (the ‘famine reaction’).

Our main focus is on neuropeptide Y (NPY) and its Y-receptors (Y1, Y2, Y4, Y5 and Y6), since many of the molecules that regulate appetite and body weight do so via interaction with the hypothalamic NPY-ergic system.

An intriguing finding in our research is that the very molecules that regulate body weight also regulate aggression, fertility as well as growth and development of lean body tissues such as muscle and bone. Therefore a second emphasis of our research is to understand how molecules in the hypothalamus influence moods and behaviour, fertility, growth, and immune system function. Our research findings have implications for the development of improved weight loss strategies, as well as novel treatments for infertility, poor lactation, dwarfism, osteoporosis (link to Paul Baldock’s group), anorexia nervosa and cancer cachexia.

Our lab has a number of conditional knockout and transgenic models that allow us to dissect the actions of signalling molecules such as dynorphins and neuropeptide Y on various cell types. Clinical collaborations allow us to collect patient data to test theories relating to modifying appetite and weight.


Staff


ronaldo EnriquezResearch Assistant
Mr Ronaldo Enriquez
Aygul AljanovaResearch Assistant
Ms Aygul Aljanova
ernie_yulyaninesim90.jpgResearch Assistant
Ms Ernie Yulyaningsih

Nikki LeePostgraduate Scholar
Ms Nikki Lee
Postgraduate Scholar
Ms Geeta Rao

Senior Research Officer
Dr Tim Karl





Shu LinSenior Research Officer
Dr Shu Lin
Laurence MaciaResearch Officer
Dr Laurence Macia
Yanchuan ShiResearch Officer
Dr Yanchuan Shi
Lei ZhangResearch Officer
Dr Lei Zhang
Natalie MitchellPhD Student
Ms Natalie Mitchell


amy_nguyen90.jpgResearch Assistant
Amy Nguyen








News

 

Importance of sex-specific testing shown in anxiety study

MEDIA RELEASE: 15 Oct 2008
A Garvan scientist has flagged an important truth for the medical research community. Like their human counterparts, male and female mice are not only different, their respective genetic responses can often be the reverse of what you'd expect from pharmacological results. This has important ramifications for laboratory and clinical testing.
 
 

Low levels of PYY hormone a very early indicator of Type 2 diabetes

MEDIA RELEASE: 10 Mar 2008
Garvan scientists have published findings showing that low levels of the hormone PYY could be used as a predictor for the development of Type 2 diabetes. Clinical studies have shown that people with a family history of Type 2 diabetes, but not yet showing signs of insulin resistance themselves, produce lower levels of PYY after eating, a very early sign of pre-diabetes.
 
 

Natural gut hormones may provide a treatment for obesity

MEDIA RELEASE: 08 Jan 2008
Garvan researchers have shown that a hormone released naturally from the gut could be used to treat obesity and Type 2 diabetes. After a meal, the hormone peptide YY (PYY) is released from the gut and acts on the brain, contributing to a feeling of satiety. Researchers foresee the use of this hormone as a weight loss medication.
 
 

Personal tools